Adventist Response to New Covid-19 Vaccine

On Wednesday 2 December, the first UK-approved Covid-19 vaccine was formally licensed and will be rolled out from next week starting with priority groups such as NHS workers.
The Pfizer vaccine is given in two doses, with three weeks in between. Results from the phase three trial indicate that the vaccine protects more than 90% of people from becoming infected by coronavirus.
With further vaccines soon to be rolled out, there has been much debate and concern with regards to the safety and…Source: https://adventist.uk/news/article/go/2020-12-03/adventist-response-to-new-covid-19-vaccine/